Login to Your Account



Avax resolves debts and plots course to restart clinical work

By Michael Fitzhugh
Staff Writer

Wednesday, August 5, 2015
Avax Technologies Inc., an immunotherapy specialist that ran into financing troubles in 2009, has settled debts it owed the Cancer Treatment Centers of America Inc. and Firebird Management LLC, repaying both parties with equity as it advances plans to re-launch a pivotal clinical study of M-Vax.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription